Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?
Authors:
Open Access
- 29 February 2016
- journal article
- review article
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 24 (4) , 268-274
Abstract
Heart failure with preserved ejection fraction, i.e. HFpEF, is highly prevalent in ageing populations, accounting for more than 50 % of all cases of heart failure in Western societies, and is closely associated with comorbidities such as obesity, diabetes and arterial hypertension. However, all large multicentre trials of potential HFpEF treatments conducted to date have failed to produce positive outcomes. These disappointing results suggest that a ‘one size fits all’ strategy may be ill-suited to HFpEF and support the use of tailored, personalised therapeutic approaches with specific treatments designed for specific comorbidity-related HFpEF phenotypes. The accumulation of a multitude of cardiovascular comorbidities over time leads to increased systemic inflammation, oxidative stress and coronary microvascular endothelial inflammation, eventually resulting in degradation of cyclic guanosine monophosphate (cGMP) via multiple pathways, thereby reducing protein kinase G (PKG) activity. The importance of cGMP-PKG pathway modulation is supported by growing evidence that suggests that this pathway may be a promising therapeutic target, evidence that is mainly based on its role in the phosphorylation of the giant cytoskeletal protein titin. This review will focus on the preclinical and early clinical evidence in the field of cGMP-enhancing therapies and PKG activation.Keywords
This publication has 52 references indexed in Scilit:
- Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament propertiesJournal of Molecular and Cellular Cardiology, 2013
- Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein CFrontiers in Physiology, 2013
- Ranolazine Improves Cardiac Diastolic Dysfunction Through Modulation of Myofilament Calcium SensitivityCirculation Research, 2012
- Sildenafil and B-Type Natriuretic Peptide Acutely Phosphorylate Titin and Improve Diastolic Distensibility In VivoCirculation, 2011
- Diabetes Mellitus Worsens Diastolic Left Ventricular Dysfunction in Aortic Stenosis Through Altered Myocardial Structure and Cardiomyocyte StiffnessCirculation, 2011
- Pulmonary Hypertension in Heart Failure With Preserved Ejection FractionCirculation, 2011
- Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary DiseaseCirculation, 2011
- Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection FractionCirculation: Heart Failure, 2011
- Novel strategies in diastolic heart failureHeart, 2010
- Role of Superoxide in the Depressed Nitric Oxide Production by the Endothelium of Genetically Hypertensive RatsHypertension, 1995